CR8001A - Composicion farmaceutica y procedimiento para el tratamiento y prevencion de la hiperplasia prostatica y la prostatitis a partir de los frutos de roystonea regia (palma real) - Google Patents

Composicion farmaceutica y procedimiento para el tratamiento y prevencion de la hiperplasia prostatica y la prostatitis a partir de los frutos de roystonea regia (palma real)

Info

Publication number
CR8001A
CR8001A CR8001A CR8001A CR8001A CR 8001 A CR8001 A CR 8001A CR 8001 A CR8001 A CR 8001A CR 8001 A CR8001 A CR 8001A CR 8001 A CR8001 A CR 8001A
Authority
CR
Costa Rica
Prior art keywords
fruits
carbon atoms
prostatitis
pharmaceutical composition
prostatic hyperplasia
Prior art date
Application number
CR8001A
Other languages
English (en)
Inventor
Melquiades Laguna Granja Abilio
Antonio Rodriguez Leyes Eduardo
Maria Mas Ferreiro Rosa
De Lourdes Arruzazabala Valma A Maria
Molina Cuevas Vivian
Luis Gonzalez Canavacioolo Victor
Carbajal Quintana Daisy
Original Assignee
Dalmer Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40210497&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR8001(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dalmer Lab Sa filed Critical Dalmer Lab Sa
Publication of CR8001A publication Critical patent/CR8001A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Esta invencion esta relacionada con la obtencion a partir de una nueva composicion farmaceutica y su proceso de obtencion a partir de los frutos de la palma real para prevenir y/o tratar la hiperplasia (HPB) y la prostatitis, asi como de la alopecia y el hirsutismo. La composicion incluye una mezcla de acidos grasos libres y/o sus esteres dentro de un rango extendido entre 8 y 28 atomos de carbono, especialmente entre 8 y 18 atomos de carbono y mas especialmente aquellos saturados de cadna lineal de 8, 10, 12, 14, 16 y 18 atomos de carbono y los monoinsaturados de 16:1 y 18:1 atomos de carbono. Esta composicion se obtiene mediante un proceso en el cual inicialmente se secan y muelen los frutos, sometiendose o no a hidrolisis basica, realizandose posteriormente una extraccion selectiva en solventes organicos.
CR8001A 2003-03-20 2005-09-20 Composicion farmaceutica y procedimiento para el tratamiento y prevencion de la hiperplasia prostatica y la prostatitis a partir de los frutos de roystonea regia (palma real) CR8001A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20030062A CU23256A1 (es) 2003-03-20 2003-03-20 EXTRACTO OBTENIDO A PARTIR DE FRUTOS DE ROYSTONEA REGIA UTILIZADO CONTRA LA HIPERPLASIA PROSTáTICA Y LA PROSTATITIS

Publications (1)

Publication Number Publication Date
CR8001A true CR8001A (es) 2006-04-21

Family

ID=40210497

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8001A CR8001A (es) 2003-03-20 2005-09-20 Composicion farmaceutica y procedimiento para el tratamiento y prevencion de la hiperplasia prostatica y la prostatitis a partir de los frutos de roystonea regia (palma real)

Country Status (24)

Country Link
US (3) US20060228429A1 (es)
EP (1) EP1623740B1 (es)
JP (1) JP4693766B2 (es)
KR (1) KR100758256B1 (es)
CN (1) CN100366246C (es)
AT (1) ATE394139T1 (es)
AU (1) AU2004222693B2 (es)
BR (1) BRPI0409056A (es)
CA (1) CA2519410C (es)
CR (1) CR8001A (es)
CU (1) CU23256A1 (es)
DE (1) DE602004013572D1 (es)
DK (1) DK1623740T3 (es)
EC (1) ECSP056028A (es)
ES (1) ES2306999T3 (es)
IL (1) IL170997A (es)
MX (1) MXPA05009905A (es)
NO (1) NO333290B1 (es)
NZ (1) NZ542361A (es)
PT (1) PT1623740E (es)
RU (1) RU2331434C2 (es)
UA (1) UA82224C2 (es)
WO (1) WO2004082696A1 (es)
ZA (1) ZA200507575B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4926395B2 (ja) * 2004-11-30 2012-05-09 学校法人 名城大学 抗mrsa用組成物
KR100769412B1 (ko) * 2006-09-13 2007-10-22 주식회사 벤스랩 Pr-119 복합생약 추출물을 함유하는 전립선 비대증의예방 및 치료용조성물
US9925162B2 (en) 2009-04-09 2018-03-27 The Regents Of The University Of Colorado Methods and compositions for inducing physiological hypertrophy
CU24143B1 (es) * 2012-06-19 2016-01-29 Cnic Ct Nac Investigaciones Ingrediente activo para el tratamiento y la prevención de la inflamación y el estrés oxidativo, así como su procedimiento de obtención a partir de los frutos de acrocomina crispa y/o acrocomia aculeata
JP6676619B2 (ja) * 2014-08-12 2020-04-08 インスティテュート デ レシェルシェ エン セミオチミエ エト エソロギエ アプリクエエ 魚への海シラミ付着阻害における使用のためのパルミトレイン酸
KR102273967B1 (ko) * 2014-10-31 2021-07-08 (주)아모레퍼시픽 인삼씨유를 함유하여 전립선 비대증을 예방 및 치료하는 조성물
JP2017214342A (ja) * 2016-06-02 2017-12-07 日清オイリオグループ株式会社 排尿障害の予防用又は改善用組成物
CN111050763B (zh) * 2017-12-26 2024-10-11 福冈大太朗 用于増毛、头皮或皮肤的改质、创伤治愈、骨形成促进或毛发的改质的药物组合物
US11896234B2 (en) 2018-01-26 2024-02-13 Fluidx Medical Technology, Llc Apparatus and method of using in situ solidifying complex coacervates for vascular occlusion
EP4082518A1 (en) 2021-04-28 2022-11-02 Cnce Innovacion, S.L. Fatty acid compositions for the treatment and prevention of hair loss and alopecia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU21519A1 (en) * 1983-03-23 1987-06-09 Inst De Quimica Y Biolog Ex Procedure to facilitate the grinding of roystonea regia fruits
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
CN1184670A (zh) * 1997-12-23 1998-06-17 张冰 一种治疗前列腺增生、前列腺炎的药物组合物
RU2140265C1 (ru) * 1998-10-27 1999-10-27 Чернобаев Николай Евгеньевич Средство для лечения и профилактики доброкачественной гиперплазии простаты (дгп), простатита, импотенции, бесплодия и рака предстательной железы

Also Published As

Publication number Publication date
US20100021574A1 (en) 2010-01-28
DE602004013572D1 (de) 2008-06-19
KR20050115920A (ko) 2005-12-08
US20100022649A1 (en) 2010-01-28
HK1084059A1 (en) 2006-07-21
BRPI0409056A (pt) 2006-03-28
RU2331434C2 (ru) 2008-08-20
EP1623740A1 (en) 2006-02-08
ZA200507575B (en) 2007-03-28
RU2005130746A (ru) 2006-06-10
PT1623740E (pt) 2008-08-12
IL170997A (en) 2010-04-15
ATE394139T1 (de) 2008-05-15
UA82224C2 (uk) 2008-03-25
AU2004222693A2 (en) 2004-09-30
AU2004222693B2 (en) 2010-08-12
NO333290B1 (no) 2013-04-29
JP2006520331A (ja) 2006-09-07
AU2004222693A1 (en) 2004-09-30
US20060228429A1 (en) 2006-10-12
ECSP056028A (es) 2006-01-27
NZ542361A (en) 2009-10-30
CN1761476A (zh) 2006-04-19
WO2004082696A1 (es) 2004-09-30
CN100366246C (zh) 2008-02-06
CA2519410C (en) 2011-04-26
NO20054847L (no) 2005-10-20
CU23256A1 (es) 2008-01-24
CA2519410A1 (en) 2004-09-30
KR100758256B1 (ko) 2007-09-13
JP4693766B2 (ja) 2011-06-01
ES2306999T3 (es) 2008-11-16
EP1623740B1 (en) 2008-05-07
MXPA05009905A (es) 2006-03-21
DK1623740T3 (da) 2008-09-08

Similar Documents

Publication Publication Date Title
ECSP056028A (es) Composición farmacéutica y procedimiento para el tratamiento y prevención de la hiperplasia prostática y la prostatitis a partir de los frutos de roystonea regia
MX2009003766A (es) Metodos para inactivar virus.
DE60237358D1 (es)
BR0115673B1 (pt) emulsão espalhável comestível e processo de preparação de uma emulsão de água em óleo comestível espalhável
CO6300899A2 (es) Un agente de control para una enfermedad post-cosecha que comprende un componente liquido que incluye un acido citrico, un alcohol, y por lo menos un componente seleccionado de un ester de acidos grasos de glicerol, poliglicerol, sorbitan, sorbitol y
DE50305176D1 (de) Verfahren zur herstellung von kerzen, bestehend aus pflanzlichen oder tierischen oelen oder fetten
DE50214513D1 (de) Vorrichtung zur erzeugung eines brennbaren gasgemisches
DE69942360D1 (de) Verfahren zur herstellung ätherischer öle durch behe öle erhältlich durch behandlung mit superkritischem wasser
ATE509085T1 (de) Verfahren zur herstellung von fettsäuren
WO2008079251A3 (en) Solvent addition and removal in the hydrogenation of catmint oil
ATE232211T1 (de) Verfahren zur herstellung von form ii kristallen des clarithromycins
AR027119A1 (es) Sintesis de silicoaluminofosfatos cristalinos
WO2003051134A3 (en) Pourable fatty dispersions
PE20090962A1 (es) Nuevas composiciones a base de taxoides
GEP20063953B (en) Method and process for producing youthful-appearing, small-pored, and smooth skin
ATE146373T1 (de) Verfahren zur gewinnung von pharmakologisch wirksamen verbindungen aus komplexen stoffgemischen
EE9900008A (et) Mittehüdraatuvate fosfatiidide madala sisaldusega glütseriidõli tootmismeetod
DE60200850D1 (de) Verfahren zur Behandlung von organischem Abfall
BR9910953A (pt) Processo para fabricar um produto carboxilatode terra rara sólido e método para melhorar asolubilidade do mesmo
WO2007065594A3 (de) Ungesättigte fettsäuren als thrombin-inhibitoren
WO2004010782A3 (fr) Procede luttant contre la propagation de virus non persistants, composition et utilisation.
Xi et al. Laser quenching+ nitriding compound treatment of 40 CrNiMoA steels.
JPS53144543A (en) Improved method of producing cylcohexane derivative
Carrascosa et al. Direct monitoring of photon induced isomerization, dissociation and electron detachment of the green fluorescent protein chromophore anion
Kurits Investigation of the combined strengthening effect on the stressed state of cylindrical sample(as a model of shaft-type part)